Dialan, Ganiel A.
HRN: 19-58-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/28/2023
05/04/2023
IV
300mg
OD
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes